Hematology/Bone Marrow Transplant and Cellular Therapy - Academic Clinician

Job Summary:

The Division of Hematology, Medical Oncology and Palliative Care seeks an academic clinician in Bone Marrow Transplant and Cellular Therapy to join our team. We are looking for candidates with a track record of clinical excellence and academic contributions as demonstrated through training and/or practice experience in caring for patients undergoing stem cell transplantation and other cellular therapies, and excellent research achievement.

Specifically, we seek a clinical and translational researcher with interest in areas such as post-transplant immunological complications, use of novel cellular therapies for cancer treatment, and use of bone marrow stem cells in transplant and regenerative medicine. The academic clinician will be expected to engage in active collaborative research and build clinical and/or translational research in the division and obtain/maintain independent extramural funding.

A competitive salary and benefits package is provided, including generous academic support.

Our stem cell transplant program has been FACT accredited since 2001, performing about 140-180 SCT yearly (60-70 allo-SCT yearly and 80-100 auto-SCT year) in recent years. We are a certified treatment center for all the FDA-approved commercial CART products for ALL, variety of lymphomas and multiple myeloma. Our CART patient volume had been doubling in the past 3 years, and we anticipate reaching 80-100 CART treatments per year with further growth in the coming years. In addition, we are actively participating in significant number of consortium and industry-sponsored cell therapy trials. We are conducting novel investigator-initiated therapeutic trials such as using alpha/beta T cell depleted haploidentical transplantation for the treatment of relapsed pediatric neuroblastoma and sarcomas. Our program is also developing institutional cell therapy trials including CRISPR/Cas9 generated CAR T cells for solid tumors and CNS malignancies, and ex vivo activated/expanded NK cells to treat neuroblastoma and osteogenic sarcoma, alpha/beta T cell and B cell depleted prophylactic donor lymphocyte infusion to prevent disease relapse after allo-SCT for patients with high risk of disease relapse.

Qualifications:

Completion of an accredited fellowship training program in hematology and/or medical oncology.

Experience in clinical, translational or basic science research, with a track record of successful publications in peer reviewed journals, strong written and verbal communication skills, commitment to diversity, equity and inclusion, evidence of excellence in teaching and current or high potential to obtain extramural funding. Through these efforts, the ability to enhance national recognition for our division and the University of Wisconsin Carbone Cancer Center.

For appointment at Associate Professor or Professor rank on CHS Track, candidates will meet criteria established by the department and as outlined in the School of Medicine and Public Health guidelines for promotion or appointment to Associate or Professor on the CHS Track.

Education:

Required
Terminal Degree
MD, DO or equivalent

License/Certification:

Required
ABIM - American Board of Internal Medicine Certification
Must have completed an accredited fellowship training program in Medical Oncology and/or Hematology

Must be eligible for a Wisconsin medical license.